Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/1993
12/07/1993CA2095944A1 Azole derivatives and antimycotic and antiaromatase agents containing them
12/07/1993CA2013799C N-alkenylbenzo(b) thieno-(3,2-b) oxazin-2,4-diones
12/06/1993CA2097766A1 Pyridyl-1,2,5-oxadiazolecarboxamide-2-oxides
12/05/1993CA2095671A1 Amino acid derivatives
12/04/1993CA2097485A1 Thiosemicarbazone derivatives
12/04/1993CA2097462A1 Angiotensin ii antagonists
12/04/1993CA2097460A1 Angiotensin ii antagonists
12/02/1993DE4217964A1 Indolocarbazol-Imide und deren Verwendung Indolocarbazole imides and the use thereof
12/01/1993EP0572166A1 New 7beta-substituted-4-aza-5a-androstan-3-ones as 5a-reductase inhibitors
12/01/1993EP0572165A1 New 7B-substituted-4-aza-5a-cholestan-ones as 5a-reductase inhibitors
12/01/1993EP0572118A1 Monoclonal antibodies to GP130 protein
12/01/1993EP0572110A2 Method of reducing or preventing toxicity associated with antiretroviral therapy by stimulation of the intracellular gluthatione level
12/01/1993EP0572014A1 Hair-growing composition containing prostaglandin I 2 derivatives
12/01/1993EP0571870A1 Cyclopentane- and -pentene-beta-amino-acids
12/01/1993EP0571575A1 Unbuffered premixed ranitidine formulation
12/01/1993EP0571546A1 Chroman and thiochromans with phenylethynyl substituents at the 7-position having retinoid-like biological activity.
12/01/1993EP0571387A1 A non-mitogenic competitive hgf antagonist
12/01/1993EP0502171A4 Composition for inducing granulocyte production or b cell production in peripheral blood
11/1993
11/30/1993US5266592 Compositions which have a physiological cooling effect, and active compounds suitable for these compositions
11/30/1993US5266578 Lipoxygenase inhibitors
11/30/1993US5266570 Piperidine derivatives, compositions and use
11/30/1993US5266326 In situ modification of alginate
11/30/1993CA2097016A1 Pharmaceutical compounds
11/30/1993CA1324761C 3-substituted-2-oxindole-1-carboxamides as inhibitors of interleukin-1 biosynthesis
11/25/1993WO1993023572A1 Therapy and diagnosis of conditions related to telomere length and/or telomerase activity
11/25/1993WO1993023546A1 Methods and compositions for increasing the sensitivity of a cell to a dna damaging agent
11/25/1993WO1993023541A1 Hepatocyte growth factor variants
11/25/1993WO1993023428A1 Calcium channel blocking polypeptides from filistata hibernalis
11/25/1993WO1993023426A1 Monomer and dimer peptides, utilization as cytoprotector agents and preparation method
11/25/1993WO1993023420A1 NEW 7β-SUBSTITUTED-4-AZA-5α-ANDROSTAN-3-ONES AS 5α-REDUCTASE INHIBITORS
11/25/1993WO1993023419A1 NEW 7β-SUBSTITUTED-4-AZA-5α-CHOLESTAN-ONES AS 5α-REDUCTASE INHIBITORS
11/25/1993WO1993023403A1 NOVEL MERCAPTOACETYLAMIDO PYRIDAZO[1,2]PYRIDAZINE, PYRAZOLO[1,2]PYRIDAZINE, PYRIDAZO[1,2-a][1,2]DIAZEPINE AND PYRAZOLO[1,2-a][1,2]DIAZEPINE DERIVATIVES USEFUL AS INHIBITORS OF ENKEPHALINASE AND ACE
11/25/1993WO1993023397A1 4-mercaptoacetylamino-[2] benzazepinone(3) derivatives, and use as enkephalinase inhibitors
11/25/1993WO1993023396A1 Fused imidazole and triazole derivatives as 5-ht1 receptor agonists
11/25/1993WO1993023391A1 Substituted indoles and azaindoles as angiotensin ii antagonists
11/25/1993WO1993023358A1 Alcohols as potassium channel openers and in treatment of urinary incontinence
11/25/1993WO1993023052A1 Use of guanylate cyclase inhibitors in the treatment of shock
11/25/1993WO1993023047A1 Use of terfenadine derivatives as antihistaminics in a hepatically impaired patient
11/25/1993WO1993023043A1 Agent for increasing somatostatin or for inhibiting decrease of somatostatin
11/25/1993WO1993023030A1 Renewal of extrinsic aging of the skin by transdermal application of selenoamino acids
11/25/1993WO1993023014A1 Chemotherapeutic drug combinations
11/25/1993WO1993019720A3 Compounds
11/25/1993WO1993017684A3 Enantiomeric hydroxylated xanthine compounds
11/25/1993DE4216829A1 Pyridyl derivs. with antithrombotic properties
11/25/1993DE4216364A1 Pyridyl derivs. with antithrombotic properties
11/25/1993CA2136091A1 Chemotherapeutic drug combinations
11/25/1993CA2135928A1 Alcohols as potassium channel openers and in treatment of urinary incontinence
11/25/1993CA2135605A1 Substituted indoles and azaindoles as angiotensin ii antagonists
11/25/1993CA2134986A1 Fused imidazole and triazole derivatives as 5-htl receptor agonists
11/25/1993CA2118012A1 Hepatocyte growth factor variants
11/25/1993CA2112262A1 Agent for increasing somatostatin or for inhibiting decrease of somatostatin
11/24/1993EP0571267A1 Use of azole derivatives for the preparation of drugs useful for inhibiting the aromatase and treating of estrogen-dependent diseases
11/24/1993EP0570519A1 Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis
11/24/1993EP0570380A1 Novel methylenebisphosphonic acid derivatives
11/24/1993CN1022832C Preparation of 3-substituted-2-oxindole derivatives
11/23/1993US5264621 Decanediylbis(carbonylamino)bis(1,5-naphthalenedisulfonic acid for AIDS treatment
11/23/1993US5264619 Anti-androgenic cyclo and bicyclo alkenes
11/23/1993US5264431 Inhibitors for proteinkinase C
11/23/1993US5264430 Enzyme inhibitor, antiinflammatory agents, treats emphysema, cystic fibrosis and arthritis
11/23/1993US5264417 Dosing an effective amount of bicozamycin ester derivatives
11/22/1993CA2091709A1 Method for inhibiting aromatase
11/21/1993CA2096616A1 7beta-substituted-4-aza-5alpha-androstan-ones as 5alpha-reductase inhibitors
11/21/1993CA2096576A1 7beta-substituted-4-aza-5alpha-cholestan-ones as 5alpha-reductase inhibitors
11/21/1993CA2096196A1 Pharmaceutical compositions
11/18/1993EP0570352A1 Novel hexapeptide
11/18/1993EP0570263A1 New alkene carboxylic acid derivatives, process for their preparation and pharmaceutic compositions containing them
11/18/1993EP0570091A1 Anthraquinone derivatives, process for their preparation and their use as medicaments
11/18/1993EP0570027A1 T cell receptor-specific for antigen polypeptides and related polynucleotides
11/18/1993EP0570022A2 Chelants possessing ortho ligating functionality and complexes thereof
11/18/1993EP0569802A1 Arylacetamides
11/18/1993EP0569795A1 Sulphonylbenzyl substituted benzo- and pyridopyridones
11/18/1993EP0569687A1 Human IL-1 cDNA sequences encoding biologically-active human IL-1 proteins
11/18/1993EP0569598A1 Benzoxazinone derivative
11/18/1993EP0569493A1 Substituted 4,6-di-tertiary-butyl-5-hydroxy-pyrimidines
11/18/1993EP0569491A1 2-substituted-4,6-di-tertiary-butyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents
11/18/1993EP0331743B1 Protein derived from living body
11/17/1993CN1078469A Substituted indole, azaindole and tetrahydro-1H-pyrrol pyrrolo |2,3-c¨ pyridin-7-one derivatives
11/17/1993CN1022754C Novel aryl-or heteroaryl-1-alkyl-pyrrole-2-carboxylic acid compounds preparation method
11/16/1993US5262565 Naphthalene derivatives
11/16/1993US5262425 α-mannosidase inhibitors
11/16/1993US5262319 Method for obtaining bone marrow free of tumor cells using transforming growth factor β3
11/16/1993CA1324383C Process for the manufacture of novel substituted aminomethanediphosphonic acids
11/13/1993CA2095801A1 Sulfonylbenzyl-substituted benzo- and pyridopyridones
11/13/1993CA2095006A1 Oxime derivatives
11/13/1993CA2095005A1 Hydroxylamine derivatives
11/11/1993WO1993022437A1 New polypeptides and peptides, nucleic acids coding for them, and their use in the field of tumor therapy, inflammation or immunology
11/11/1993WO1993022431A1 Constitutive and inducible epidermal vector systems
11/11/1993WO1993022430A1 Development of a vector to target gene expression to the epidermis of transgenic animals
11/11/1993WO1993022424A1 RECOMBINANT STIMULATING FACTOR OF THE neu RECEPTOR
11/11/1993WO1993022309A1 4-imidomethyl-1-[2'phenyl-2'oxoethyl-] piperidines as serotonin 5ht2-antagonists, their preparation and use in therapy
11/11/1993WO1993022304A1 Phenylderivate as inhibitors of atp citrate lyase
11/11/1993WO1993022302A1 N-aryloxy(thio)alkyl-azacycloalkanes useful as calcium channel antagonists
11/11/1993WO1993021992A1 Laser treatment
11/11/1993WO1993021946A1 Methods for treating interleukin-1 and tumor necrosis factor mediated diseases
11/11/1993WO1993021936A1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF
11/11/1993WO1993021927A1 Minimizing progestin associated breakthrough bleeding
11/11/1993WO1993021926A1 Minimizing progestin associated breakthrough bleeding
11/11/1993WO1993021924A1 Drug for increasing the level of testosterone in the body
11/11/1993WO1993021915A1 Pharmaceutical compositions for inhibiting bone loss containing 3 and 4-substituted 2(5h)-furanones
11/11/1993WO1993021907A1 Pharmaceutical preparation and process for its manufacture
1 ... 1440 1441 1442 1443 1444 1445 1446 1447 1448 1449 1450 1451 1452 1453 1454 1455 1456 1457 1458 1459 1460 ... 1564